XML 118 R109.htm IDEA: XBRL DOCUMENT v3.24.2.u1
SEGMENT INFORMATION Segment Assets (Details) - USD ($)
$ in Millions
 12 Months Ended
Oct. 31, 2023
Oct. 31, 2022
Segment Reporting Information [Line Items]    
Total assets $ 10,763 $ 10,532
Long-term investments 164 195
Deferred tax assets 338 259
Right-of-use asset 154 150
Other assets 708 686
Other Noncurrent Assets [Member]    
Segment Reporting Information [Line Items]    
Deferred tax assets 284 246
Operating Segments    
Segment Reporting Information [Line Items]    
Capital Expenditures 298 291
Total assets 8,024 8,313
Operating Segments | Life Sciences and Applied Markets    
Segment Reporting Information [Line Items]    
Capital Expenditures 64 71
Total assets 3,161 3,241
Operating Segments | Diagnostics and Genomics    
Segment Reporting Information [Line Items]    
Capital Expenditures 212 187
Total assets 3,966 4,203
Operating Segments | Agilent CrossLab    
Segment Reporting Information [Line Items]    
Capital Expenditures 22 33
Total assets 897 869
Corporate, Non-Segment    
Segment Reporting Information [Line Items]    
Cash and Cash Equivalents 1,590 1,053
Prepaid Expense, Current 139 119
Long-term investments 164 195
Long term and other receivables 127 134
Deferred tax assets 284 246
Right-of-use asset 154 150
Other assets $ 281 $ 322